Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 76
Last updated 2017-01-10
Summary
The purpose of this study is to assess safety, Pharmacokinetics/Pharmacodynamics and Urate Lowering Effect of URC102 in gout patients.
Conditions
- Gout
- Hyperuricemia
Interventions
- DRUG
-
URC102
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 69 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2016-08-31
- Completion
- 2016-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Phase III Trial of Febuxostat in Korea Gout Patients
NCT00821392 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
NCT00080210 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients
NCT05119686 ·Status: COMPLETED ·Phase: PHASE2
-
Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
NCT04511702 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
NCT00985127 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
NCT02287818 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
NCT06139393 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
NCT00675103 ·Status: COMPLETED ·Phase: PHASE3
-
Arthritis Research UK Gout Treatment Trial - Phase 2
NCT01477346 ·Status: COMPLETED ·Phase: NA
-
Rasburicase Treatment in Chronic Gouty Arthritis
NCT05312268 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
NCT05513976 ·Status: UNKNOWN ·Phase: PHASE2
-
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
NCT00174967 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Intravenous Uricase-PEG 20
NCT01021241 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
NCT05504083 ·Status: COMPLETED ·Phase: PHASE2
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879 ·Status: COMPLETED ·Phase: NA
-
Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
NCT01508702 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Exploratory Clinical Study of KUX-1151
NCT02190786 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Intramuscular Uricase-PEG 20
NCT01038947 ·Status: UNKNOWN ·Phase: PHASE1